Raysearch Laboratories Ab Class B · OMXSTO:RAY_B
Raysearch Laboratories Ab Class B — Q4 2021 Earnings Presentation
9 slides from Raysearch Laboratories Ab Class B's earnings presentation, Feb 23, 2022
Slide 1: RaySearch Laboratories AB Year-End Report, February 23, 2022
RAYSEARCH LABORATORIES AB YEAR-END REPORT, FEBRUARY 23, 2022
Slide 2: Agenda
AGENDA Q4 2021 in short Financials Final remarks Q&A
Slide 3: Q4 – Returning to Growth
Q4 – RETURNING TO GROWTH Strong order intake in fourth quarter, +44% End of period backlog SEK 1,363 M Increased customer activities ASTRO, user meetings Several large orders Lanzhou Ion Therapy Co Proton International Arkansas Collaboration agreements Mevion, IBA
Slide 4: Continued Development of Product Portfolio
CONTINUED DEVELOPMENT OF PRODUCT PORTFOLIO Long-term R&D activities continues according to plan in Q4 Comprehensive cancer The next generation oncology RayStation 11B treatment planning information system RayCare 5B RayCommand 2B Continued development, launch A unified treatment control system Advan
Slide 5: Q4 Result
Q4 RESULT Order intake, Net Sales & Operating Result Q4 (Oct - Dec) Order Intake increased 44% to 345 MSEK 239 345 Revenue increased 18% to 188 MSEK 250 188 Operating result was -17 MSEK compared 160 to -15 MSEK last year 150 MSEK 50 -15 -17 -50 20Q4 21Q4 Order Intake Net Sales Operating Result
Slide 6: Income Statement
INCOME STATEMENT Net Sales, Operating Costs and Operating License revenue and support revenue Result Q4 (Oct - Dec) increased during Q4 250 188 160 Operating expenses increased due to 150 increased sales activities, relocation of HQ 50 and higher R&D costs MSEK -50 -15 -17 Operating result was -17 M
Slide 7: Balance Sheet and Cash Flow
BALANCE SHEET AND CASH FLOW Tangible fixed assets increased with Cash from operating activities before changes more than 450 MSEK, due to the move to in working capital was positive 68 MSEK during a new HQ the period in spite of the negative result Intangible fixed assets increased due to the Operat
Slide 8: Strong Platform for Future Growth
STRONG PLATFORM FOR FUTURE GROWTH Market condidtions improve as Covid-19 recedes Increased demand for software solutions that allow efficiency gains We expect to return to growth in 2022 without increasing costs
Slide 9: Q&A
O&A pay Search Laboratories
RaySearch Laboratories — Q4 2021 Earnings Presentation on 6ix